Concepedia

Publication | Open Access

Liver <scp>GPBAR1</scp> Associates With Immune Dysfunction in Primary Sclerosing Cholangitis and Its Activation Attenuates Cholestasis in Abcb4−/− Mice

10

Citations

34

References

2025

Year

Abstract

Our study provides evidence for the therapeutic potential of selective GPBAR1 agonists in intestinal inflammation-associated cholestasis, warranting the evaluation of BAR501 in PSC patients.

References

YearCitations

Page 1